Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: the importance of physician-patient interaction and communication
出版年份 2017 全文链接
标题
Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: the importance of physician-patient interaction and communication
作者
关键词
-
出版物
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 31, Issue 6, Pages 1014-1020
出版商
Wiley
发表日期
2017-02-22
DOI
10.1111/jdv.14178
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population
- (2016) Jalpa A. Doshi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment Satisfaction of Patients with Psoriasis
- (2015) M Schaarschmidt et al. ACTA DERMATO-VENEREOLOGICA
- Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective
- (2015) Christopher Ross et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis
- (2015) Arnd Jacobi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis
- (2015) Amir Goren et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Benefits of an asthma education program provided at primary care sites on asthma outcomes
- (2015) Louis-Philippe Boulet et al. RESPIRATORY MEDICINE
- Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
- (2015) Mingliang Zhang et al. Patient Preference and Adherence
- An Educational Program That Contributes to Improved Patient and Parental Understanding of Atopic Dermatitis
- (2014) Ji Yeon Shin et al. Annals of Dermatology
- Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
- (2014) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Non-adherence and measures to improve adherence in the topical treatment of psoriasis
- (2014) I. Zschocke et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Strategies to maximize treatment success in moderate to severe psoriasis: establishing treatment goals and tailoring of biologic therapies
- (2014) Elizabeth Brezinski et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
- (2013) M. Esposito et al. BRITISH JOURNAL OF DERMATOLOGY
- Drug survival rates in patients with psoriasis after treatment with biologics
- (2013) Yoshinori Umezawa et al. JOURNAL OF DERMATOLOGY
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities
- (2011) Sue Ann Chan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
- (2011) Kenneth B. Gordon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
- (2009) Sudeep Karve et al. CURRENT MEDICAL RESEARCH AND OPINION
- The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers
- (2009) Susanne Jank et al. PHARMACY WORLD & SCIENCE
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started